| For: | Hussain MS, Jakhmola V, Goyal K, Rekha A, Sultana A, Ali H, Gupta G. Targeting the NAD+/SIRT1 axis: A metabolic strategy to overcome oxaliplatin resistance in colorectal cancer. World J Gastroenterol 2025; 31(21): 106530 [PMID: 40538510 DOI: 10.3748/wjg.v31.i21.106530] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v31/i21/106530.htm |
| Number | Citing Articles |
| 1 |
Rajeev Kumar Sahoo, Zahid Alim Ansari, Sambit Kumar Pradhan, Bijesh Kumar Biswal. Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer. Pathology - Research and Practice 2025; 275 doi: 10.1016/j.prp.2025.156243
|
| 2 |
Sichong Qiu, Shaocong Li, Yuzuo Chen, Xiumei Ma, Hongfang Fu, Biao Zhao. Mechanisms and advances of drug resistance in colorectal cancer: A systematic overview of multi-layered regulatory networks. Translational Oncology 2026; 71 doi: 10.1016/j.tranon.2026.102886
|
| 3 |
Zhennan Ma, Xiuqing Gong, Fuquan Liu. The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1784749
|
| 4 |
Yi-Jian Tsai, Wei-Ni Lyu, Nai-Shun Liao, Pei-Chun Chen, Mong-Hsun Tsai, Eric Y. Chuang. Gut microbiome-based machine learning model for early colorectal cancer and adenoma screening. Gut Pathogens 2025; 17(1) doi: 10.1186/s13099-025-00750-z
|
| 5 |
C. Sudlow Leland, Du Junwei, Shahverdi Kiana, Zhou Haiying, Y. Berezin Mikhail. Lineage-Specific Disruption of Hematopoiesis by Oxaliplatin: Mechanisms of Erythropoietin Resistance and Immune Suppression. Journal of Hematology and Oncology Research 2026; 4(4) doi: 10.14302/issn.2372-6601.jhor-25-5944
|